NonExomics

The AI engine Fit Assessment

Beta

NonExomics leverages machine learning to discover new patterns in genomic data and expand therapeutics for rare diseases.

Blurb

NonExomics develops therapeutics to diagnose and cure diseases emanating from the nonexome.

HQ Location

United States

Founded

2021

Employees

1 - 10

Total funding raised

$200.00K

Last Funding Event

Non-Equity Assistance, March 16, 2022

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Genomic Data Analysis

Operator of a healthcare-based data analytics company intended to diagnose and cure diseases. The company's platform integrates genomics, transcriptomic, and proteomics data by utilizing proprietary machine-learning approaches to predict structures of noneconomic proteins and identify and prioritize disease-specific noneconomic targets, enabling researchers to find cures for rare diseases.